We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biochip Array Technology Detects Multiple Analytes

By LabMedica International staff writers
Posted on 31 Oct 2011
A versatile multiplex polymerase chain reaction (PCR) and proprietary Biochip Array Technology is exemplified by the broad range of array formats available.

The Biochip Array Technology allows simultaneous detection of multiple analytes from a single sample for efficient and cost effective testing, providing laboratories with innovative, intuitive technology. More...


The array formats include single nucleotide polymorphism (SNP) genotyping, based on an innovative primer design that can discriminate sequences, which differ only at one base; harnessing gene expression, particularly in a multiplex array, providing a powerful insight into disease processes, such as cancer progression; rapid, sensitive, multiplex detection of viral, bacterial and protozoan pathogens; and a rapid mutation profiling array, consisting of a highly multiplexed PCR coupled to hybridization of target DNA sequences to spatially tethered probes on a biochip array.

The Sexually Transmitted Infection (STI) Array is capable of simultaneously detecting ten of the most common STIs from a single patient sample and the Respiratory Pathogens Array simultaneously detects up to 22 viral and bacterial infectious agents of the respiratory tract from bronchoalveolar lavage, nasopharyngeal swab, sputum, or saliva. The multiplex PCR and proprietary Biochip Array Technology in the analyzer known as the Evidence is a product of Randox Molecular Diagnostics (Crumlin, UK). It is well suited to the larger laboratory with a throughput of more than 1,500 tests per hour.

Personalized cancer medicine based on genetic profiling of individual tumors is regarded as the treatment strategy of the future. In respect of this, Randox Molecular Diagnostics will soon be launching a specific breast cancer-gene array for the rapid and accurate detection of mutations to stratify patients for antiepidermal growth factor receptor (EGFR)-targeted therapy. This is important, as recent clinical evidence indicates that in addition to the Kirsten rat sarcoma viral oncogene (KRAS) mutational status, other molecular alterations such as the V-raf murine sarcoma viral oncogene homolog B1 (BRAF) and Phosphoinositide 3-kinase oncogene (PIK3CA), mutations can occur in a tumor, precluding response to anti-EGFR therapy.

Related Links:
Randox Molecular Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.